Literature DB >> 28051263

Psychological factors associated with NAFLD/NASH: a systematic review.

B Macavei1, A Baban, D L Dumitrascu.   

Abstract

OBJECTIVE: Nonalcoholic fatty liver disease (NAFLD) represents one of the most common chronic liver diseases worldwide. So far, the pathogenesis of NAFLD and its more severe variant nonalcoholic steatohepatitis (NASH) is yet unclear, with many mechanisms being proposed as possible causes. This article aims to review the psychological factors associated with NAFLD/NASH.
MATERIALS AND METHODS: Three main categories of factors have been investigated: emotional, cognitive and behavioral. Five electronic databases were searched, limited to studies published in the English language, during the period 2005-2015: PubMed, Thomson ISI - Web of Science, Scopus, ProQuest, and ScienceDirect.
RESULTS: Results indicated the most relevant emotional factors to be depression and anxiety. The areas of investigation for cognitive functioning concern those contents and processes related to the ability to initiate and maintain lifestyle changes. The most important behavioral factors identified are physical activity, nutrition/food intake and substance consumption: coffee, alcohol, cigarettes.
CONCLUSIONS: Some of the factors identified act as protective factors, other as vulnerability factors. NAFLD/NASH may be considered a cognitive-behavioral disease, the most effective management being lifestyle changes, with emphasis on diet and exercise.

Entities:  

Mesh:

Year:  2016        PMID: 28051263

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  15 in total

Review 1.  Exercising the hepatobiliary-gut axis. The impact of physical activity performance.

Authors:  Emilio Molina-Molina; Raquel Lunardi Baccetto; David Q-H Wang; Ornella de Bari; Marcin Krawczyk; Piero Portincasa
Journal:  Eur J Clin Invest       Date:  2018-06-14       Impact factor: 4.686

2.  Methamphetamine-Induced Cognitive Deficits and Psychiatric Symptoms Are Associated with Serum Markers of Liver Damage.

Authors:  Tingting Zhao; Changping Zhai; Hongmei Song; Yanhai Wu; Chuanhui Ge; Yonglin Zhang; Hongxia Xu; Zhengsuo Chi; Hui Chu; Wei Shi; Xiaodong Cheng; Xin Li; Mengdi Ma; Mengyuan Xu; Jiaqi Hu; Ya Xie; Yanan Lin; Hongxu Chen; Yiting Li; Dongliang Jiao
Journal:  Neurotox Res       Date:  2019-11-05       Impact factor: 3.911

3.  Anxiety and Depression in Metabolic-Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk.

Authors:  Abdulrahman Ismaiel; Mihail Spinu; Daniel-Corneliu Leucuta; Stefan-Lucian Popa; Bogdan Augustin Chis; Mihaela Fadgyas Stanculete; Dan Mircea Olinic; Dan L Dumitrascu
Journal:  J Clin Med       Date:  2022-04-28       Impact factor: 4.964

4.  Population-based body-brain mapping links brain morphology with anthropometrics and body composition.

Authors:  Tiril P Gurholt; Tobias Kaufmann; Oleksandr Frei; Dag Alnæs; Unn K Haukvik; Dennis van der Meer; Torgeir Moberget; Kevin S O'Connell; Olof D Leinhard; Jennifer Linge; Rozalyn Simon; Olav B Smeland; Ida E Sønderby; Adriano Winterton; Nils Eiel Steen; Lars T Westlye; Ole A Andreassen
Journal:  Transl Psychiatry       Date:  2021-05-18       Impact factor: 6.222

5.  Cognitive Changes and Brain Volume Reduction in Patients with Nonalcoholic Fatty Liver Disease.

Authors:  Branka Filipović; Olivera Marković; Vesna Đurić; Branislav Filipović
Journal:  Can J Gastroenterol Hepatol       Date:  2018-02-27

6.  Association of MTTP gene variants with pediatric NAFLD: A candidate-gene-based analysis of single nucleotide variations in obese children.

Authors:  Dongling Dai; Feiqiu Wen; Shaoming Zhou; Zhe Su; Guosheng Liu; Mingbang Wang; Jianli Zhou; Fusheng He
Journal:  PLoS One       Date:  2017-09-27       Impact factor: 3.240

Review 7.  Cardiovascular Risk in Fatty Liver Disease: The Liver-Heart Axis-Literature Review.

Authors:  Abdulrahman Ismaiel; Dan L Dumitraşcu
Journal:  Front Med (Lausanne)       Date:  2019-09-13

8.  Self-rated health and risk of incident non-alcoholic fatty liver disease: A cohort study.

Authors:  Yoosoo Chang; Jin-Won Noh; Joo Young Cheon; Yejin Kim; Young Dae Kwon; Seungho Ryu
Journal:  Sci Rep       Date:  2020-03-02       Impact factor: 4.379

Review 9.  Nonalcoholic Fatty Liver Disease.

Authors:  Lingling Ding; Yvonne Oligschlaeger; Ronit Shiri-Sverdlov; Tom Houben
Journal:  Handb Exp Pharmacol       Date:  2022

10.  Correlation of blood glucose, serum chemerin and insulin resistance with NAFLD in patients with type 2 diabetes mellitus.

Authors:  Zhengjun Zhang; Jijun Wang; Hongmei Wang
Journal:  Exp Ther Med       Date:  2018-01-16       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.